robert
pc
etchison
jr
bond
cw
rapid
quantit
assay
titrat
bovin
viru
diarrhoeamucos
diseas
viru
vet
microbiol
end
point
dilut
microtitr
assay
describ
use
titrat
cytopath
noncytopath
isol
bovin
viru
diarrhoeamucos
diseas
viru
indirect
immunofluoresc
use
detect
infect
mdbk
cell
well
terasaki
plate
viru
titr
deriv
number
uninfect
well
use
poisson
distribut
assay
simpl
fast
econom
titr
cytopath
viru
determin
microtitr
assay
standard
plaqu
assay
equival
bovin
viru
diarrhoeamucos
diseas
viru
bvdv
type
speci
genu
pestiviru
famili
togavirida
westaway
et
al
viru
occur
biotyp
isol
either
cytopath
cbvdv
noncytopath
ncbvdv
tissu
cultur
intermedi
biotyp
also
observ
mcclurkin
coria
cytopath
bvdv
readili
titrat
use
standard
plaqu
assay
ncbvdv
present
problem
sever
differ
assay
develop
year
titrat
ncbvdv
exploit
variou
properti
ncbvdv
interfer
cytopathogen
cbvdv
gillespi
et
al
itoh
et
al
enhanc
cytopathogen
newcastl
diseas
viru
ndv
end
assay
omori
et
al
inhibit
protect
cell
polyriboinosin
acid
polyribocytidyl
acid
poli
c
vesicular
stomat
viru
vsv
pinba
assay
infect
mai
contribut
montana
agricultur
experi
station
author
correspond
address
sonnav
rossi
product
plaqu
monolay
stain
sever
day
neutral
red
straver
detect
ncbvdvinfect
cell
immunofluoresc
ferneliu
frey
liess
rae
et
al
immunoperoxidas
techniqu
katz
et
al
hyera
et
al
present
paper
describ
rapid
quantit
end
point
dilut
microtitr
procedur
titrat
either
biotyp
bvdv
assay
adapt
origin
develop
robb
titrat
simian
viru
robb
martin
murin
coronavirus
robb
bond
bvdv
isol
use
studi
cytopath
isol
singer
nadl
oregon
tgac
illc
ssdc
noncytopath
isol
new
tgan
illn
ssdn
isol
kind
gift
dr
arlan
meclurkin
dr
teven
bolin
nation
anim
diseas
center
ame
ia
mdbk
cell
atcc
ccl
maintain
ham
dme
irvin
scientif
supplement
equin
serum
hyclon
laboratori
inc
black
angu
heifer
seroneg
viru
neg
bvdv
infect
isol
bvdv
intranas
instil
ml
infect
cell
cultur
fluid
titr
x
infecti
unit
iu
viru
stock
viru
titrat
method
describ
paper
use
hyperimmun
serum
nadl
isol
bvdv
provid
dr
steven
bolin
eight
week
later
anim
boost
ml
emuls
cell
cultur
fluid
incomplet
freund
adjuv
administ
intramuscularli
serum
prepar
blood
collect
week
later
assay
adapt
describ
robb
martin
tenfold
serial
dilut
viru
made
suspens
x
mdbk
cell
ham
plu
equin
serum
suspens
dispend
terasaki
plate
nunc
tl
place
well
altern
uninfect
cell
dispens
well
infect
next
day
serial
dilut
viru
prevent
dehydr
incub
ml
distribut
around
insid
edg
plate
plate
incub
h
c
medium
aspir
plate
rins
twice
cold
dulbecco
phosphatebuff
salin
pb
cold
absolut
methanol
flood
cold
absolut
methanol
five
minut
later
methanol
remov
plate
allow
dri
room
temperatur
plate
use
immedi
store
terasaki
plate
rehydr
rins
pb
primari
antiserum
dilut
pb
contain
porcin
gelatin
sigma
l
dispens
well
terasaki
plate
plate
incub
h
humid
atmospher
incub
plate
rins
time
pb
contain
tween
sigma
secondari
antiserum
fluoresc
rabbit
antibovin
gamma
globulin
antibodi
incorpor
dilut
dispens
primari
antiserum
plate
incub
h
c
wash
twice
pb
contain
tween
twice
distil
water
min
per
wash
prior
observ
cell
fluoresc
well
fill
pb
laboratori
olympu
invert
microscop
epifluoresc
attach
use
observ
well
bvdvspecif
fluoresc
entir
bottom
well
fit
field
view
x
object
len
make
score
simpl
epifluoresc
water
immers
object
len
use
view
well
upright
microscop
viru
titr
calcul
number
uninfect
well
use
poisson
distribut
sixwel
plate
seed
x
mdbk
cell
per
well
incub
overnight
next
day
medium
aspir
ml
serial
dilut
viru
dispens
onto
monolay
viru
allow
adsorb
h
regular
agit
monolay
overlaid
ml
seaplaqu
agaros
fmc
agaros
allow
gel
room
temperatur
plate
incub
invert
three
day
later
cell
fix
ml
glutaraldehyd
agaros
remov
monolay
stain
crystal
violet
ethanol
plaqu
count
altern
cell
stain
least
h
ml
neutral
red
dark
fix
ml
glutaraldehyd
agaros
remov
plaqu
count
initi
set
microtitr
assay
bovin
hyperimmun
serum
rais
nadl
isol
bvdv
kind
gift
dr
steven
bolin
use
found
work
well
assay
cbvdv
isol
assay
ncbvdv
isol
prove
difficult
level
virusspecif
fluoresc
observ
often
bare
background
increas
chanc
score
fals
posit
neg
ferneliu
indic
fluoresc
antiserum
rais
ncbvdv
better
detect
biotyp
rais
cbvdv
therefor
decid
antiserum
rais
would
suitabl
assay
stock
anim
veterinari
research
laboratori
screen
identifi
cattl
seroneg
bvdv
use
plaqu
reduct
assay
anim
screen
persist
bvdv
infect
cocultiv
peripher
blood
leucocyt
mdbk
cell
mdbk
cell
subsequ
assay
presenc
bvdv
indirect
immunofluoresc
three
seroneg
bvdvfree
anim
identifi
one
select
immunis
describ
materi
method
specif
antiserum
bvdv
check
compar
immunofluoresc
bvdvinfect
uninfect
mdbk
cell
un
infect
cell
dilut
antiserum
result
elimin
nonspecif
fluoresc
bvdvinfect
cell
readili
detect
shown
fig
cell
infect
bvdv
distinct
fluoresc
confin
cytoplasm
uninfect
cell
either
fluoresc
low
level
fluoresc
entir
cell
bvdvspecif
fluoresc
detect
earli
h
postinfect
pi
mdbk
cell
data
shown
care
plate
score
h
accuraci
microtitr
assay
enhanc
incub
cell
h
allow
viru
propag
amplifi
viral
antigen
infect
well
increas
rate
plate
score
microscop
reduc
error
due
score
falseneg
well
better
score
plate
contain
higher
viru
dilut
first
probabl
uninfect
well
level
nonspecif
fluoresc
assess
allow
accur
score
laboratori
viru
titr
calcul
use
simpl
turbo
pascal
borland
comput
program
compil
version
program
pcdo
format
may
obtain
send
format
disk
author
viru
titr
calcul
poisson
distribut
use
follow
equat
p
number
uninfect
well
multipl
infect
per
well
iu
per
ttl
exampl
titr
calcul
titr
singer
isol
tabl
determin
follow
twentyfour
well
uninfect
dilut
give
valu
p
equal
ln
p
obtain
titr
per
millilitr
origin
viru
stock
multipli
reciproc
dilut
case
result
titr
iu
larg
statist
error
occur
titr
calcul
plate
either
well
infect
robb
martin
accuraci
assay
also
depend
number
well
use
per
dilut
laboratori
half
well
terasaki
plate
well
depend
whether
plate
gener
use
per
dilut
plaqu
detect
noncytopath
detect
plaqu
ncbvdv
ssdn
isol
indic
put
noneytopath
isol
contamin
cbvdv
surpris
isol
cbvdv
ssoc
isol
recov
anim
suffer
chronic
bvd
bolin
person
commun
appear
biotyp
total
separ
noncytopath
viru
stock
henc
plaqu
format
b
crystal
violet
plaqu
assay
perform
duplic
plate
describ
text
plate
stain
day
neutral
red
stain
h
illustr
show
well
inocul
dilut
viru
assess
accuraci
microtitr
assay
compar
plaqu
assay
isol
bvdv
cbvdv
ncbvdv
titrat
use
method
observ
oregon
isol
plaqu
readili
detect
use
neutral
red
crystal
violet
stain
fig
reason
plaqu
assay
carri
duplic
plate
day
one
plate
stain
neutral
red
crystal
violet
titr
taken
averag
duplic
plate
except
oregon
could
determin
plate
stain
neutral
red
titr
determin
individu
assay
close
agreement
tabl
although
data
present
singl
experi
similar
result
consist
produc
detect
plaqu
ncbvdv
ssdn
isol
indic
put
noncytopath
isol
contamin
cbvdv
surpris
isol
cbvdv
ssdc
isol
recov
anim
suffer
chronic
bvd
bolin
person
commun
appear
biotyp
total
separ
noncytopath
viru
stock
henc
plaqu
format
sever
advantag
end
point
dilut
microtitr
assay
describ
bvdv
assay
method
especi
ncbvdv
major
consider
assay
use
titrat
either
biotyp
bvdv
result
comparison
plaqu
microtitr
assay
cbvdv
isol
give
equival
result
reason
assum
titr
ncbvdv
isol
determin
use
microtitr
assay
equal
accur
assay
also
adapt
measur
serum
neutralis
titr
biolog
clone
bvdv
isol
desir
could
also
adapt
immunoenzym
mode
detect
katz
et
al
hyera
et
al
howard
et
al
justewicz
et
al
microtitr
assay
certain
advantag
standard
plaqu
assay
cbvdv
isol
take
less
time
set
requir
less
term
materi
take
less
space
incub
read
day
care
less
day
ncbvdv
isol
microtitr
assay
distinct
advantag
assay
method
assay
direct
assay
infecti
bvdv
wherea
assay
indirect
compar
assay
microtitr
assay
much
simpler
faster
less
prone
error
requir
challeng
viru
unlik
interfer
assay
gillespi
et
al
revers
plaqu
assay
itoh
et
al
requir
cbvdv
challeng
viru
interfer
assay
also
suffer
illdefin
end
point
lead
statist
inaccuraci
pinba
maisonnav
rossi
end
omori
et
al
assay
requir
challeng
vsv
ndv
respect
pinba
assay
vari
accuraci
cell
line
rossi
kiesel
cell
infect
ncbvdv
resist
challeng
vsv
end
assay
shown
less
sensit
assay
ncbvdv
itoh
et
al
compar
direct
assay
ncbvdv
microtitr
assay
statist
accur
due
larger
number
replic
previous
describ
end
point
dilut
assay
ferneliu
frey
liess
hyera
et
al
katz
et
al
laboratori
ncbvdv
plaqu
occasion
observ
neutral
red
stain
origin
describ
straver
inconsist
plaqu
format
time
requir
stain
make
method
less
ideal
problem
encount
microtitr
assay
describ
due
lack
specif
low
titr
primari
antibvdv
antiserum
use
use
antiserum
rais
ncbvdv
isol
allevi
problem
present
studi
